ALK and neuroblastoma: We also put into context the utility of tumour-derived exosomes and cfDNA for detecting crucial alterations to ALK and MYCN genes in NB patient primary and relapse samples [18,39,42], while comparative studies of the diagnostic accuracy of tumour-derived exosomes and cfDNA are still largely lacking.